Correction: Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents

Documenti analoghi

• Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy
  di: Dirk Schadendorf, et al.
  Pubblicazione: (2020-10-01)
• Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients
  di: Domenico Galati, et al.
  Pubblicazione: (2023-05-01)
• Correction: Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents
  Pubblicazione: (2023-07-01)
• 1541 Stability of the gut microbiota during anti-pd1 immunotherapy defines complete response in melanoma patients
  di: Massimo Barberis, et al.
  Pubblicazione: (2023-11-01)
• Oncostatin M upregulates CD73 via the MAPK pathway in keratinocytes to promote an adenosine-dependent anti-inflammatory response in psoriasis
  di: Caterina Giraulo, et al.
  Pubblicazione: (2026-02-01)